1 week ago

PepGen (PEPG) Stock Soars 146% After Positive Drug Trial Results

TLDR PepGen stock traded at $5.76 on Tuesday, up about 146%. The 10 mg/kg cohort showed 46.5% average splicing correction at week 13. No serious or severe adverse events were reported. An FDA partial clinical hold on the FREEDOM2 study is still in place. Cash of $104.8M should fund operations into 2028. PepGen (PEPG) stock [...]

The post PepGen (PEPG) Stock Soars 146% After Positive Drug Trial Results appeared first on Blockonomi.

Source: Blockonomi →